CausalSentinel

Protein Dossier — CRISPLD2 (Cysteine-rich secretory protein LCCL domain-containing 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Lung cancer -0.261 0.0845 0.00199 Wald ratio 1 cis NA
Thalamus volume 84.5 31.2 0.00683 Wald ratio 1 cis NA
Diastolic blood pressure automated reading -0.027 0.0113 0.0173 Wald ratio 1 cis NA
Diagnoses - main ICD10: K40 Inguinal hernia -0.197 0.0831 0.0175 Wald ratio 1 cis NA
Squamous cell lung cancer -0.278 0.13 0.032 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes -0.0423 0.0199 0.034 Wald ratio 1 cis NA
Clear cell ovarian cancer 0.384 0.191 0.0438 Wald ratio 1 cis NA
Coronary heart disease 0.103 0.0518 0.0463 Wald ratio 1 cis NA
Myocardial infarction 0.115 0.0594 0.0522 Wald ratio 1 cis NA
Systolic blood pressure automated reading -0.0218 0.0113 0.0542 Wald ratio 1 cis NA
Pallidum volume 17.6 9.53 0.0645 Wald ratio 1 cis NA
Diagnoses - main ICD10: I48 Atrial fibrillation and flutter -0.255 0.138 0.0653 Wald ratio 1 cis NA
…and 65 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

111 association rows across 44 traits (98 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Height 2e-84 rs7204018 24 GCST90245848 no MR -> candidate analysis
Serum levels of protein CRISPLD2 8e-33 rs144759316 2 GCST90089149 no MR -> candidate analysis
creatinine (minimum, inv-norm transformed) 1e-28 rs1874014 2 GCST90475232 no MR -> candidate analysis
creatinine (mean, inv-norm transformed) 7e-27 rs1874014 2 GCST90475229 no MR -> candidate analysis
estimated glomerular filtration rate (eGFR, maximum, inv-nor 4e-26 rs1874014 2 GCST90475280 no MR -> candidate analysis
estimated glomerular filtration rate (eGFR, mean, inv-norm t 4e-26 rs1874014 2 GCST90475282 no MR -> candidate analysis
Seropositivity (peptide co-occurrence module 12: H. pylori, 3e-25 rs1421350113 1 GCST90295934 no MR -> candidate analysis
Cysteine-rich secretory protein LCCL domain-containing 2 lev 2e-23 rs183935383 3 GCST90247162 no MR -> candidate analysis
Inguinal hernia 3e-20 rs4238714 15 GCST90239723 MR: beta=-0.197, p=0.0175 (cis)
Diverticular disease 4e-20 rs17111 3 GCST90301393 MR: beta=-0.129, p=0.287 (cis)
Cysteine-rich secretory protein LCCL domain-containing 2 lev 5e-19 rs12921670 3 GCST90240842 no MR -> candidate analysis
Blood protein levels 2e-18 rs60910901 1 GCST006585 no MR -> candidate analysis
…and 32 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 209 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
diverticular disease 0.873 common-variant locus MR: beta=-0.129, p=0.287 (cis)
Inguinal hernia 0.816 common-variant locus MR: beta=-0.197, p=0.0175 (cis)
Abnormality of the skeletal system 0.803 common-variant locus no MR -> candidate analysis
Hernia 0.742 common-variant locus MR: beta=-0.197, p=0.0175 (cis)
appendicitis 0.656 common-variant locus MR: beta=-0.18, p=0.368 (cis)
Hernia of the abdominal wall 0.654 common-variant locus no MR -> candidate analysis
vein disorder 0.627 common-variant locus no MR -> candidate analysis
pelvic organ prolapse 0.528 common-variant locus no MR -> candidate analysis
lymphatic system disorder 0.504 common-variant locus no MR -> candidate analysis
coronary artery disorder 0.475 common-variant locus no MR -> candidate analysis
male reproductive organ cancer 0.472 common-variant locus no MR -> candidate analysis
digestive system disorder 0.467 common-variant locus no MR -> candidate analysis
abdominal abscess 0.467 common-variant locus no MR -> candidate analysis
aortic valve stenosis 0.447 common-variant locus no MR -> candidate analysis
abdominal aortic aneurysm 0.431 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 11 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1.2e-10, LOEUF=0.843 — LoF-tolerant
GWAS Catalog 107 unique SNPs / 220 rows
ClinVar 249 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance